44 Stocks Moving in Wednesday's Pre-Market Session

Author: Lisa Levin | September 09, 2020 07:01am

Gainers

Superconductor Technologies Inc (NASDAQ:SCON) rose 45.8% to $0.35 in pre-market trading after declining 7% on Tuesday. Superconductor Technologies issued a letter to stockholders.
Trillium Therapeutics Inc. (NASDAQ:TRIL) rose 37.4% to $13.00 in pre-market trading after the company announced an update for data from its ongoing TTI-622 and TTI-621 dose escalation studies. Trillium Therapeutics also disclosed a $25 million equity investment from Pfizer.
Watford Holdings Ltd. (NASDAQ:WTRE) rose 31.5% to $23.50 in pre-market trading after Reuters reported that a consortium led by Arch Capital Group made an offer worth $500 million to acquire Watford.
Comstock Mining Inc. (NYSE:LODE) rose 19.8% to $1.27 in pre-market trading after the company entered into a Mineral Exploration and Mining Lease Agreement with the Sutro Tunnel Company.
RAVE Restaurant Group, Inc. (NASDAQ:RAVE) shares rose 15.9% to $0.58 in pre-market trading after climbing around 11% on Tuesday. Rave Restaurant Group's Pizza Inn, last month, partnered with RetailStack for point of sale system.
Predictive Oncology Inc. (NASDAQ:POAI) rose 11.2% to $0.9730 in pre-market trading.
Hermitage Offshore Services Ltd. (NYSE:PSV) rose 10.6% to $0.3980 in pre-market trading after dipping around 44% on Tuesday. Hermitage Offshore Services recently announced appeal of NYSE delisting determination.
Antero Resources Corporation (NYSE:AR) rose 10.7% to $3.01 in pre-market trading after declining over 7% on Tuesday.
Moxian, Inc. (NASDAQ:MOXC) shares rose 8.4% to $2.45 in pre-market trading. Moxian, last week, reported a share exchange deal with Btab Group.
iBio, Inc. (NASDAQ:IBIO) rose 8.2% to $2.05 in pre-market trading. iBio recently announced it entered into an exclusive worldwide license agreement with Planet Biotechnology for the development of Planet's COVID-19 therapeutic candidate, ACE2-Fc.
Phreesia Inc (NYSE:PHR) rose 7.9% to $32.85 in pre-market trading after reporting Q2 results.
9F Inc. (NASDAQ:JFU) rose 7.4% to $1.30 in pre-market trading after declining over 3% on Tuesday.
Novavax, Inc. (NASDAQ:NVAX) rose 7.4% to $91.60 in pre-market trading. Novavax shares fell over 8% on Tuesday after several drug companies, including Novavax, signed a pledge committing to not file for approval of a COVID-19 vaccine until late-stage studies demonstrate safety and efficacy.
AIM ImmunoTech Inc. (NYSE:AIM) rose 7.4% to $2.04 in pre-market trading after gaining over 7% on Tuesday. AIM ImmunoTech recently said it decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model.
Tesla, Inc. (NASDAQ:TSLA) shares rose 7.2% to $354.01 in pre-market trading. Tesla shares fell over 21% on Tuesday, marking the worst day of declines for the automaker, after it was left out of the prestigious S&P 500 index.
Ocugen, Inc. (NASDAQ:OCGN) rose 6.5% to $0.3461 in pre-market trading. Ocugen reported that the Nasdaq has granted the company 180-day extension to regain compliance with bid price rule.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) rose 6.2% to $10.20 in pre-market trading. Inovio Pharmaceuticals, yesterday, reported a coronavirus vaccine manufacturing agreement with Thermo Fisher.
Precipio, Inc. (NASDAQ:PRPO) rose 6% to $2.50 in pre-market trading after gaining over 9% on Tuesday. Precipio is expected to host a shareholder call to discuss its COVID-19 progress and future plans today.
Kamada Ltd. (NASDAQ:KMDA) rose 5.7% to $9.70 in pre-market trading after the company received a $10.6 million missile fuze systems order. Kamada shares gained around 5% on Tuesday after the company announced the completion of enrollment and initial interim results from its Phase 1/2 clinical trial in Israel for the Plasma-derived Hyperimmune Immunoglobulin products as a potential treatment of coronavirus.
Vaxart, Inc. (NASDAQ:VXRT) rose 5.6% to $5.09 in pre-market trading. Vaxart yesterday announced its oral COVID-19 vaccine candidate induces potent systemic and mucosal immune response in preclinical studies.
Workhorse Group Inc. (NASDAQ:WKHS) rose 5.5% to $22.55 in pre-market trading after gaining over 8% on Tuesday. Workhorse recently announced agreements with Hitachi to support higher production. Hitachi will review Workhorse's operations and provide recommendations to support increased production requirements.
Nikola Corporation (NASDAQ:NKLA) rose 5.3% to $52.70 in pre-market trading. Nikola shares jumped around 41% on Tuesday after the company announced a strategic partnership with General Motors.
Chembio Diagnostics, Inc. (NASDAQ:CEMI) rose 5.3% to $4.00 in pre-market trading after the company submitted EUA application for new DPP SARS-CoV-2 IgM/IgG test system.
Qiagen NV (NYSE:QGEN) rose 3.5% to $49.91 in pre-market trading after the company announced the launch of its rapid portable test that can analyze 30+ samples per hour for Coronavirus antigen.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

Shiloh Industries, Inc. (NASDAQ:SHLO) fell 24% to $0.5322 in pre-market trading. Shiloh Industries, last week, received court approval of "First Day" motions to support business operations..
Slack Technologies, Inc. (NYSE:WORK) fell 16.5% to $24.50 in pre-market trading. Slack reported upbeat earnings and sales for the second quarter. However, the company’s billing growth slowed in the quarter.
SeaChange International Inc (NASDAQ:SEAC) fell 11.9% to $1.18 in pre-market trading after the company reported downbeat Q2 results.
Gevo, Inc. (NASDAQ:GEVO) shares fell 10.6% to $0.93 in pre-market trading. Gevo shares tumbled over 10% on Tues after the company issued a business update.
NextDecade Corporation (NASDAQ:NEXT) shares fell 10.3% to $2.09 in pre-market trading after jumping over 75% on Tuesday.
Tiffany & Co. (NYSE:TIF) fell 10.1% to $109.50 in pre-market trading. Tiffany filed a lawsuit against LVMH to enforce merger agreement. Tiffany Files Lawsuit Against LVMH To Enforce Merger Agreement
Athenex Inc (NASDAQ:ATNX) fell 9.4% to $13.00 in pre-market trading after the company reported a 10 million share offering.
Altimmune, Inc (NASDAQ:ALT) shares fell 8.1% to $11.62 in pre-market trading. Altimmune, last week, announced completion of multiple dose toxicity and toxicokinetic studies of ALT-801.
Luby's, Inc. (NYSE:LUB) fell 7.7% to $2.05 in pre-market trading. Luby's shares climbed 111% on Tuesday after the company’s board adopted plan of liquidation and dissolution.
Check-Cap Ltd. (NASDAQ:CHEK) fell 7.5% to $0.36 in pre-market trading after reporting a 25.9 million share common stock offering.
Globus Maritime Limited (NASDAQ:GLBS) fell 5.9% to $0.11 in pre-market trading after declining over 4% on Tuesday.
SRAX, Inc. (NASDAQ:SRAX) fell 5.4% to $2.91 in pre-market trading after rising around 8% on Tuesday. SRAX announced plans to acquire LD Micro.
SCWorx Corp. (NASDAQ:WORX) fell 5.4% to $1.76 in pre-market trading after jumping over 22% on Tuesday.
Vroom Inc (NASDAQ:VRM) fell 5.3% to $53.25 in pre-market trading. Vroom, raised its guidance for the third quarter. However, the company’s latest forecast was still below analysts’ expectations. Vroom also disclosed a 10.35 million share common stock offering.
Seritage Growth Properties (NYSE:SRG) fell 5.2% to $14.85 in pre-market trading.
Blink Charging Co. (NASDAQ:BLNK) fell 5.1% to $6.13 in pre-market trading. Blink Charging recently received over $1 million follow-on order from InterEnergy for EV charging equipment for deployment in The Dominican Republic.
Lululemon Athletica Inc. (NASDAQ:LULU) fell 4.8% to $332.99 in pre-market trading. Lululemon reported better-than-expected results for its second quarter. Sales at company-owned stores declined 51% year over year to $287.2 million, while direct-to-consumer sales surged 155% to $554.3 million.
T2 Biosystems, Inc. (NASDAQ:TTOO) fell 4.8% to $1.20 in pre-market trading. T2 Biosystems, last week, announced CMS approval of new technology add-on payment for the T2Bacteria panel.
Casey's General Stores Inc. (NASDAQ:CASY) fell 4.7% to $166.00 in pre-market trading. Casey's reported upbeat earnings for its first quarter, while sales were slightly below estimates.
Albireo Pharma Inc (NASDAQ:ALBO) shares fell 4.1% to $38.00 in pre-market trading after the company reported a 3 million share offering. Albireo Pharma shares jumped 45% on Tuesday after the company disclosed that its Phase 3 trial of odevixibat met both primary endpoints.